Skip to content

Clinical Study On The Effectiveness Of Mridvikachandanadi Kashaya In Increased Per Vaginal Bleeding.

Clinical Study On The Effectiveness Of Mridvikachandanadi Kashaya In Asrigdara. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056443
Enrollment
30
Registered
2023-08-11
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N921- Excessive and frequent menstruation with irregular cycle

Interventions

None listed

Sponsors

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.With signs and symptoms of Asrigdara for at least 2months. 2•Aged between 18-45years. 3.With angamarda and vedana during menstrual cycle. 4.Willing to sign the informed consent. •Endometrial thickness

Exclusion criteria

Exclusion criteria: 1.known case of Systemic hemorrhagic disorders 2.known case of Sexually transmitted diseases. 3.using Intra Uterine Contraceptive Devises or Oral Contraceptive pills. 4.known case of pelvic pathologies. (fibroid, adenomyosis, endometriosis etc) 5.known case of anaemia. 6.known case of Benign and malignant growth in uterus and ovaries.

Design outcomes

Primary

MeasureTime frame
Reduction of per vaginal bleeding during menstrual cycleTimepoint: Assessment will be done at baseline follow up on 30th 60th & 90th day

Secondary

MeasureTime frame
it might regularize the flow & duaration of bleeding pattern it might help in dysfunctional uterine bleeding Hb%,Amount of menstrual blood loss,Duration of bleeding,Presence of clots,Dysmenorrhea,Bodyache ,USG(abdomen and pelvis), Endometrial thickness will be repeated on 90th day for result Timepoint: 90 days

Countries

India

Contacts

Public ContactDr Apoorva R N

Sri Dharmasthala Manjunatheshwara College Of Ayurveda And Hospital,Hassan

gaya3hassan@gmail.com09844437917

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026